Autism Answers Back

When the ABA Market Calls It Growth, We Call It What It Is

AABabafactory Applied Behavior Analysis for Autism Market Surges with Impressive 6.9% CAGR… That’s the headline from a news release pushing ABA as a booming industry through 2032. It lists corporate “leaders” like CARD, BlueSprig, Centria, Hopebridge. It calls this growth “opportunity” for stakeholders.

Nowhere does it mention the people who live with the consequences.

Growth Framed as Progress — Without Proof

The Missing Realities

How Market Language Masks Harm

When market reports talk about “early intervention,” “behavior modification,” “classroom management,” they’re not talking about creating space for autistic ways of being. They’re talking about shaping those ways into something easier for others to manage — and selling that as a service.

The mechanism is clear: pathology frame + investor appetite = scale without safeguards. The beneficiary is the corporate provider. The cost is carried in autistic bodies and lives.

Questions That Should Be Driving the Conversation

Not All Growth Is Progress

A market can surge for a harmful product just as easily as for a helpful one. When ABA’s global footprint is celebrated in investor language, we’re not seeing a win for autistic people. We’re watching the industrialization of forced compliance.

The revenue chart is going up. That’s not the same as progress.